[go: up one dir, main page]

Liu et al., 2011 - Google Patents

Engineering monovalent quantum dot− antibody bioconjugates with a hybrid gel system

Liu et al., 2011

Document ID
9268883250199584745
Author
Liu H
Gao X
Publication year
Publication venue
Bioconjugate Chemistry

External Links

Snippet

Monovalent nanoparticles are of strong current interest in biological imaging and detection due to their potential for stoichiometric binding with target molecules. We report the preparation of monovalent quantum dot− antibody bioconjugates using a high-resolution …
Continue reading at pubs.acs.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients

Similar Documents

Publication Publication Date Title
Liu et al. Engineering monovalent quantum dot− antibody bioconjugates with a hybrid gel system
Giovanelli et al. Highly enhanced affinity of multidentate versus bidentate zwitterionic ligands for long-term quantum dot bioimaging
Breus et al. Zwitterionic biocompatible quantum dots for wide pH stability and weak nonspecific binding to cells
Anderson et al. Systematic investigation of preparing biocompatible, single, and small ZnS-capped CdSe quantum dots with amphiphilic polymers
Bilan et al. Quantum dot surface chemistry and functionalization for cell targeting and imaging
Medintz et al. Intracellular delivery of quantum dot− protein cargos mediated by cell penetrating peptides
Lees et al. Experimental determination of quantum dot size distributions, ligand packing densities, and bioconjugation using analytical ultracentrifugation
Rizvi et al. Semiconductor quantum dots as fluorescent probes for in vitro and in vivo bio-molecular and cellular imaging
Allen et al. InAs (ZnCdS) quantum dots optimized for biological imaging in the near-infrared
Daou et al. Effect of poly (ethylene glycol) length on the in vivo behavior of coated quantum dots
Clarke et al. Covalent monofunctionalization of peptide-coated quantum dots for single-molecule assays
Murcia et al. Design of quantum dot-conjugated lipids for long-term, high-speed tracking experiments on cell surfaces
Perng et al. Elucidating the role of surface coating in the promotion or prevention of protein corona around quantum dots
Xu et al. Stable, compact, bright biofunctional quantum dots with improved peptide coating
Dubavik et al. Penetration of amphiphilic quantum dots through model and cellular plasma membranes
Rees et al. Dextran-functionalized semiconductor quantum dot bioconjugates for bioanalysis and imaging
Mittal et al. Biotin-4-fluorescein based fluorescence quenching assay for determination of biotin binding capacity of streptavidin conjugated quantum dots
Saha et al. Synthesis of nanobioconjugates with a controlled average number of biomolecules between 1 and 100 per nanoparticle and observation of multivalency dependent interaction with proteins and cells
Dif et al. Small and stable peptidic PEGylated quantum dots to target polyhistidine-tagged proteins with controlled stoichiometry
Tasso et al. Oriented bioconjugation of unmodified antibodies to quantum dots capped with copolymeric ligands as versatile cellular imaging tools
Han et al. Zwitterion and oligo (ethylene glycol) synergy minimizes nonspecific binding of compact quantum dots
Kloust et al. Poly (ethylene oxide) and polystyrene encapsulated quantum dots: highly fluorescent, functionalizable, and ultrastable in aqueous media
Thiry et al. Fluorescence properties of hydrophilic semiconductor nanoparticles with tridentate polyethylene oxide ligands
Han et al. Real-time imaging of endocytosis and intracellular trafficking of semiconducting polymer dots
Lix et al. Dextran functionalization of semiconducting polymer dots and conjugation with tetrameric antibody complexes for bioanalysis and imaging